Fate Therapeutics
FATE • NASDAQ
Fate Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bahram Valamehr, with a market cap of $136.0M.
Market Cap$136.0M
Employees181.0
CEOBahram Valamehr
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Fate Therapeutics FAQ
Common questions about Fate Therapeutics
Fate Therapeutics is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $1.5M.
Fate Therapeutics has approximately 181 employees.